Chimeric optogenetic opsin (None established; chimeric opsin or chimeric rhodopsin may be used informally)

A chimeric optogenetic opsin is a synthetic protein constructed by combining domains from different light-sensitive opsins (such as rhodopsin, melanopsin, or microbial channelrhodopsins) to create a novel actuator with tailored biophysical properties for optogenetic control of cellular signaling or membrane potential. These molecules possess distinct spectral sensitivity, G protein coupling, and/or ion conductivity depending on the phylogenetic origin and engineered modifications. Chimeric opsins are instrumental in neuroscience research, enabling precise light-triggered manipulation of defined neural pathways, study of complex behaviors, and exploration of potential therapeutic strategies (e.g., for vision restoration in retinal degeneration). However, "chimeric optogenetic opsin" does not refer to a single well-characterized endogenous molecule or clinical drug target, but rather to an expanding toolkit of engineered proteins with customizable functions.

Other names

Chimeric opsinChimeric rhodopsinEngineered optogenetic actuatorSynthetic optogenetic tool

Light-induced conformational change activates either G protein signaling (for GPCR-based chimeras) or opens/closes ion channel (for channel-based chimeras). In chimeric GPCRs, domain swapping may confer the ability to activate particular G protein pathways in response to light rather than ligand. In ion channel chimeras, mutations or recombination may alter ion selectivity, kinetics, or spectral sensitivity.